Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis

Eva Sykova; Dasa Cizkova; Sarka Kubinova

doi:10.3389/fcell.2021.770243

Corrigendum: Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis

Front Cell Dev Biol. 2021 Oct 28:9:770243. doi: 10.3389/fcell.2021.770243. eCollection 2021.

Authors

Eva Sykova¹, Dasa Cizkova^{1

2}, Sarka Kubinova³

Affiliations

¹ Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.
² Centre for Experimental and Clinical Regenerative Medicine, University of Veterinary Medicine and Pharmacy in Kosice, Kosice, Slovakia.
³ Department of Optical and Biophysical Systems, Institute of Physics of the Czech Academy of Sciences, Prague, Czechia.

Abstract

[This corrects the article DOI: 10.3389/fcell.2021.695900.].

Keywords: amyotrophic lateral sclerosis; biomaterials; cell therapy; conditioned medium; exosomes; mesenchymal stem cells; neurodegenerative diseases; spinal cord injury.

Publication types

Published Erratum